Literature DB >> 11252151

How to pick optimal acute treatment for migraine headache.

M Sanchez del Rio1, S Silberstein.   

Abstract

Drug selection for the acute treatment of migraine is based on comorbid disorders, coexistent diseases, and the patient's pain profile and specific needs and expectations. Patients should be instructed to tailor their treatment strategy to meet their specific needs by varying their medications according to pain intensity. This will aid in successful headache management, by increasing compliance and decreasing disability and cost.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11252151     DOI： 10.1007/s11916-001-0085-z

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


  14 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

2.  Treatment of a prolonged migrainous aura with intravenous furosemide.

Authors:  T D Rozen
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

3.  Excessive oxygen or glucose supply does not alter the blood flow response to somatosensory stimulation or spreading depression in rats.

Authors:  T Wolf; U Lindauer; A Villringer; U Dirnagl
Journal:  Brain Res       Date:  1997-07-04       Impact factor: 3.252

4.  Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan.

Authors:  V Pfaffenrath; G Cunin; G Sjonell; S Prendergast
Journal:  Headache       Date:  1998-03       Impact factor: 5.887

5.  Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine.

Authors:  A Peikert; W J Becker; E A Ashford; C Dahlof; H Hassani; R J Salonen
Journal:  Eur J Neurol       Date:  1999-01       Impact factor: 6.089

Review 6.  Advances in migraine management.

Authors:  T A Lewis; G D Solomon
Journal:  Cleve Clin J Med       Date:  1995 May-Jun       Impact factor: 2.321

7.  Warning symptoms in migraine: characteristics and therapeutic implications.

Authors:  J Waelkens
Journal:  Cephalalgia       Date:  1985-12       Impact factor: 6.292

8.  An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score.

Authors:  W F Stewart; R B Lipton; J Whyte; A Dowson; K Kolodner; J N Liberman; J Sawyer
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

9.  Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials.

Authors:  R K Cady; F Sheftell; R B Lipton; S O'Quinn; M Jones; D G Putnam; A Crisp; A Metz; S McNeal
Journal:  Clin Ther       Date:  2000-09       Impact factor: 3.393

10.  Treatment of acute migraine with subcutaneous sumatriptan.

Authors:  R K Cady; J K Wendt; J R Kirchner; J D Sargent; J F Rothrock; H Skaggs
Journal:  JAMA       Date:  1991-06-05       Impact factor: 56.272
View more
  1 in total

1.  Do over-the-counter medications for migraine hinder the physician?

Authors:  Thais Brown Tonore; Deborah S King; Sara L Noble
Journal:  Curr Pain Headache Rep       Date:  2002-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.